Global Isothermal Nucleic Acid Amplification Technologies Market 2014-2018

Apr 25, 2014, 13:37 ET from Research and Markets

DUBLIN, Apr. 25, 2014 /PRNewswire/ -- Research and Markets ( has announced the addition of the "Global Isothermal Nucleic Acid Amplification Technologies Market 2014-2018" report to their offering.

The Molecular Diagnostics industry is experiencing a rapid shift toward an increase in the process automation and integration of sample analysis in single miniaturized devices. Miniaturization offers scope for reduced sample volume, enabling the end-user to automate and analyze the sample.

Among all the diagnostic methods, nucleic acid testing remains the method with the most potential for conducting analysis in miniaturized devices. Although PCR is one of the standard techniques for conducting amplification reaction, the method is quite complex due to the need for repeated thermo cycling and cooling, and it consumes more energy in the process.

As an alternative to PCR, isothermal nucleic amplification circumvents the need for repeated denaturation and cooling as the amplification reaction occurs under isothermal conditions. This greatly aids in the design of microfluidic chips for conducting molecular diagnostics. Most of these microfluidic devices adopting isothermal nucleic acid amplification methods are in the R&D phase. It is expected that the increase in miniaturization of nucleic acid-based diagnostics will boost the growth of the market.

According to the report, one of the major drivers in this market is the technological advancements. Isothermal amplification-based technologies and their variants are being developed to address the diagnosis of many infectious disease- causing pathogens. Based on the mechanisms of the strand displacement properties of DNA polymerases, helicases, and other catalytic factors, many isothermal amplification methods have been developed.

Further, the report states that one of the major challenges in this market is the intense competition from PCR-based diagnostics. PCR-based diagnostics still remains the gold standard method for the amplification of nucleic acids owing to the popularity and wide range of product manufacturers.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Key Topics Covered:

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

04. Market Research Methodology

05. Introduction

06. Market Landscape

07. Market Segmentation by Application

08. Market Segmentation by Technology


10. Geographical Segmentation

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

19. Key Vendor Analysis

Companies Mentioned:

  • Becton
  • Dickson and Co.
  • bioMerieux S.A.
  • Hologic Inc.
  • Novartis International AG.
  • Quidel Corp.
  • Alere Inc.
  • Axxin Pvt Ltd.
  • Eiken Chemical Co. Ltd.
  • Great Basin Corp.
  • Lucigen Corp.
  • Meridian Bioscience Inc.
  • New England Biolabs Inc.
  • Optigene Ltd.

For more information visit

Media Contact: Laura Wood, +353-1-481-1716,

SOURCE Research and Markets